Largest health care biotech companies by total liabilities

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

Amgen leads the 24 health care biotech companies ranked by total liabilities, at A$122.9B, ahead of Gilead Sciences (A$54.6B) and Biogen (A$16.8B). Figures as of 19 Nov 2026, 18:01 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenA$122.9B
Median
A$1.1B
Combined market value
A$1.25T
Countries
5

Market values as of .

All countries
Health Care
Biotech
AUD
Clear filters
Largest health care biotech companies by total liabilities
#CompanyTotal liabilities ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareA$122.9BA$357.3BA$660.57 0.77% down 32% up United States
2Gilead SciencesGILD · Health CareA$54.6BA$311.2BA$250.94 0.98% down 35% up United States
3BiogenBIIB · Health CareA$16.8BA$54.7BA$369.98 1.87% down 49% up United States
4ModernaMRNA · Health CareA$5.5BA$122.8BA$303.41 2.81% up 780% up United States
5BioNTechBNTX · Health CareA$4.6BA$30.3BA$122.32 2.04% down 14% down Germany
6QiagenQGEN · Health CareA$3.8BA$15.3BA$74.24 0.12% down 9% up Netherlands
7Halozyme TherapeuticsHALO · Health CareA$3.7BA$15.8BA$138.80 3.39% down 39% up United States
8Neurocrine BiosciencesNBIX · Health CareA$2.1BA$23.9BA$236.40 3.21% down 17% up United States
9argenxARGX · Health CareA$2BA$89BA$1,415.24 0.26% up 2% up Belgium
10ImmunityBioIBRX · Health CareA$1.5BA$10.6BA$9.96 0.90% down 232% up United States
11RepligenRGEN · Health CareA$1.3BA$16.4BA$257.15 0.69% down 12% up United States
12Revolution MedicinesRVMD · Health CareA$1.1BA$52.5BA$242.59 1.21% up 129% up United States
13ExelixisEXEL · Health CareA$1BA$24.2BA$99.29 3.05% down 63% up United States
14Bio-TechneTECH · Health CareA$717.6MA$17.1BA$109.05 0.05% down 24% up United States
15CRISPR TherapeuticsCRSP · Health CareA$515MA$5.8BA$59.73 0.90% down 18% down Switzerland
16VaxcytePCVX · Health CareA$475.7MA$14.1BA$88.95 1.35% up 23% up United States
17Adaptive BiotechnologiesADPT · Health CareA$431.5MA$7BA$43.10 0.98% up 74% up United States
18Kodiak SciencesKOD · Health CareA$291.2MA$9.7BA$147.65 0.66% up 399% up United States
19Twist BioscienceTWST · Health CareA$253.3MA$12.1BA$176.96 1.42% up 346% up United States
20Kymera TherapeuticsKYMR · Health CareA$244.7MA$15.5BA$182.06 0.22% up 87% up United States
21Scholar Rock HoldingSRRK · Health CareA$238.1MA$9.2BA$75.64 5.08% up 26% up United States
22Krystal BiotechKRYS · Health CareA$171.3MA$14.1BA$476.06 0.67% up 54% up United States
23ImmunovantIMVT · Health CareA$156.6MA$10.2BA$49.10 1.30% down 46% up United States
24CG OncologyCGON · Health CareA$58.5MA$10.9BA$122.58 2.17% up 97% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 1.4997 AUD).

Questions and answers

Which health care biotech companies rank first by total liabilities?

Amgen (A$122.9B), Gilead Sciences (A$54.6B) and Biogen (A$16.8B) are the top three of the 24 health care biotech companies ranked by total liabilities as of 19 Nov 2026, 18:01 UTC.

How many health care biotech companies are in this ranking?

24 are ranked by total liabilities.

What are these health care biotech companies worth together?

The 24 health care biotech companies ranked by total liabilities have a combined market value of A$1.25T as of 19 Nov 2026, 18:01 UTC.

What does ranking by total liabilities measure?

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

Cite this page

Funkfolio, “Largest health care biotech companies by total liabilities”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=total-liabilities

Underlying data: Yahoo Finance; SEC EDGAR.